AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Director's Dealing Jul 9, 2014

7734_dirs_2014-07-09_3abb7731-a3d6-476c-b543-fee67cd16a1d.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9111L

Judges Scientific PLC

09 July 2014

Judges Scientific plc (the "Company")

9 July 2014

Director/PDMR Shareholding

Judges Scientific has been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 7 July 2014 by the Trustees of the Share Incentive Plan on behalf of three Directors of the Company, as follows:

A total of eight Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company, to which the Company added a further eight Ordinary Shares under the "matching" provisions of the Plan's rules.  His resulting interest in the Company is 916,456 Ordinary Shares representing 15.37 per cent of the issued Ordinary share capital.  In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.

One Ordinary Share was purchased on behalf of David Barnbrook, a Director and the Chief Operating Officer of the Company.  His resulting interest in the Company is 22,491 Ordinary Shares representing 0.38 per cent of the issued Ordinary share capital.  In addition, he holds options over 28,325 Ordinary Shares under the Company's Share Option Plans.

A total of eight Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company, to which the Company added a further eight Ordinary Shares under the "matching" provisions of the Plan's rules.  His resulting interest in the Company is 57,973 Ordinary Shares representing 0.97 per cent of the issued Ordinary share capital.  In addition, he holds options over 7,875 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1870.00p per Ordinary Share.  Purchases of a further 559 Ordinary Shares were made on the same date and at the same price on behalf of 64 other members of staff under the Plan.

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777 or 07775 896 491

Website:

Judges Scientific: www.judges.uk.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBLGDRXDGBGSC

Talk to a Data Expert

Have a question? We'll get back to you promptly.